The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients

Bernard Charbonnel, John Dormandy, Erland Erdmann, Massimo Massi-Benedetti, Allan Skene, PROactive Study Group, Gordon Murray

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients'. Together they form a unique fingerprint.

Medicine & Life Sciences